ストックスクリーナーアプリを入手
22.30
2.35%
-0.485
前日終値:
$22.79
開ける：
$22.88
24時間の取引高:
122.83K
Relative Volume:
0.25
時価総額：
$1.23B
収益：
-
当期純損益:
$-102.09M
株価収益率:
-21.24
EPS:
-1.05
ネットキャッシュフロー:
$-108.72M
1週間 パフォーマンス:
+3.42%
1か月 パフォーマンス:
+3.70%
6か月 パフォーマンス:
+148.22%
1年 パフォーマンス:
+401.24%
1日の値動き範囲:
$22.07
$22.94
1週間の範囲:
$20.49
$23.47
52週間の値動き範囲:
$3.91
$26.18
Dbv Technologies Adr Stock (DBVT) Company Profile
名前
Dbv Technologies Adr
セクター
電話
33(0)155427878
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Compare DBVT vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DBVT
Dbv Technologies Adr
|
22.31 | 1.25B | 0 | -102.09M | -108.72M | -1.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.50 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
769.77 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
730.28 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.49 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
294.34 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-12-03 | 開始されました | Guggenheim | Buy |
| 2025-05-29 | 再開されました | Goldman | Sell |
| 2023-01-04 | アップグレード | Societe Generale | Hold → Buy |
| 2022-12-16 | ダウングレード | Goldman | Neutral → Sell |
| 2022-05-10 | ダウングレード | Goldman | Buy → Neutral |
| 2021-09-14 | アップグレード | Societe Generale | Hold → Buy |
| 2021-01-22 | ダウングレード | Societe Generale | Hold → Sell |
| 2020-11-02 | アップグレード | Societe Generale | Sell → Hold |
| 2020-08-06 | ダウングレード | Societe Generale | Buy → Sell |
| 2020-08-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-17 | ダウングレード | Stifel | Buy → Hold |
| 2020-01-09 | アップグレード | Stifel | Hold → Buy |
| 2019-12-16 | 開始されました | Citigroup | Buy |
| 2019-09-05 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-06-17 | 開始されました | Goldman | Buy |
| 2018-12-20 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2018-12-20 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | ダウングレード | Jefferies | Buy → Hold |
| 2018-12-20 | ダウングレード | Stifel | Buy → Hold |
| 2017-10-31 | アップグレード | Societe Generale | Sell → Hold |
| 2017-10-24 | ダウングレード | Societe Generale | Buy → Sell |
| 2017-10-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | 開始されました | Deutsche Bank | Buy |
| 2017-03-16 | アップグレード | Societe Generale | Hold → Buy |
| 2016-09-26 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-03 | 開始されました | Barclays | Overweight |
| 2015-10-23 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Dbv Technologies Adr (DBVT) 最新ニュース
DBV Technologies to Participate in Upcoming March Investor Conferences - markets.businessinsider.com
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 - ChartMill
DBV Technologies stock surges on new peanut patch trial data - Investing.com
Phase 3 VITESSE data highlighted by DBV Technologies (NASDAQ: DBVT) - Stock Titan
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting - The Manila Times
DBV Technologies Highlights Additional Data from Successful - GlobeNewswire
DBV Technologies (DBVT) Projected to Post Earnings on Thursday - Defense World
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail
DBV Technologies launches $150M ATM offering - MSN
BioImpact LLC reports 9.99% DBV Technologies (DBVT) stake via shares and warrants - Stock Titan
European Equities Traded in the US as American Depositary Receipts Lower Wednesday - MSN
DBV Technologies to Participate in Biotech Summit - Intellectia AI
DBV Technologies to Present VIASKIN® Data at AAAAI 2026 - Intellectia AI
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting - The Manila Times
DBV Technologies S.A. - Via Ritzau
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit - markets.businessinsider.com
Biotech summit to feature DBV Technologies CEO fireside chat - Stock Titan
DBV Technologies (NASDAQ:DBVT) Upgraded at Wall Street Zen - Defense World
DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
European ADRs Slip As Winners And Losers Split By Region - Finimize
European ADRs Inched Higher As GSK And Telefonica Jumped - Finimize
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN) - The Globe and Mail
DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above 50 Day Moving Average – What’s Next? - Defense World
European ADRs Started The Week Higher In US Trading - Finimize
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing - Sahm
DBV Technologies (NASDAQ:DBVT) Shares Gap Up – Still a Buy? - Defense World
European ADRs Slipped, But Biotech Names Still Stole The Show - Finimize
DBV Technologies Announces €166.7 Million in Gross Proceeds - GlobeNewswire
DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025 - GlobeNewswire Inc.
Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Benzinga
DBV Technologies stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com
DBV Technologies S.A. (NASDAQ:DBVT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times
European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading - MSN
How M&A Unlocked A Biotech Rebound In 2025— And What Comes Next? - Sahm
The Insider Report: A Tape Fitting for the Holiday - Sahm
Dbv Technologies Adr (DBVT) 財務データ
収益
当期純利益
現金流量
EPS
Dbv Technologies Adr (DBVT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| EPIC Bpifrance | Member of 10% owner group |
Dec 17 '25 |
Sale |
4.85 |
2,076,990 |
10,070,232 |
8,595,472 |
| EPIC Bpifrance | Member of 10% owner group |
Dec 18 '25 |
Sale |
4.19 |
1,292,103 |
5,413,912 |
7,303,369 |
| Mohideen Pharis | Chief Medical Officer |
Nov 20 '25 |
Sale |
2.88 |
6,496 |
18,708 |
103,153 |
| Mohideen Pharis | Chief Medical Officer |
Nov 21 '25 |
Sale |
2.77 |
1,624 |
4,498 |
101,529 |
| Mohideen Pharis | Chief Medical Officer |
Jul 29 '25 |
Sale |
2.22 |
464 |
1,030 |
109,649 |
| Mohideen Pharis | Chief Medical Officer |
May 22 '25 |
Sale |
1.84 |
397 |
730 |
110,113 |
0.50%
大文字化:
|
ボリューム (24 時間):